Health analytics

Global market access strategy

Our strategic services help clients to navigate uncertainties and maximise value throughout the product lifecycle.

We enable market access through provision of insights that inform development of optimal payer evidence, pricing and access strategies, while also providing solutions that help execute on the strategy and set our clients' assets up for commercial success. Our tailored approach aims to provide market access insights and solutions across all stages of the product lifecycle.

Our featured insights

We link global value and access strategies to local health system needs and priorities

At LCP Health Analytics, we recognise that securing access and reimbursement for novel therapies demands a strategic approach tailored to each product and market. Our dedicated market access team goes beyond generic consulting models to provide an integrated, bespoke service reflecting your specific needs for value demonstration, pricing strategy, and payer engagement.

We foster early payer involvement through our global payer network for value demonstration, access and pricing, enabling successful launches. We quantify the full range of tangible and intangible value elements of your product to payers and health systems using real-world evidence. We also have extensive experience in co-creating innovative outcome-based agreements responsive to healthcare priorities.

With real-world analytics integral to our market access approach, we stand distinct from typical market access consultancies through linking global value strategies to local health system needs and priorities. Our goal is to help you achieve broad, rapid and sustainable patient access.

We support our clients across the following areas:

Global market access consulting

Pricing, reimbursement and competitor landscape assessment
Payer research/advisory boards
Market access strategy/roadmap
Portfolio planning including indication sequencing and country prioritisation
Business development/licensing evaluation i.e. opportunity assessment/asset due diligence

Payer value communications

Value story/messaging
Global value dossier strategy and development, including AMCP and formulary communications
Payer value decks and access toolkits
Objection handling
Payer simulation workshops
Internal training and preparedness
Payer focused publications

Payer evidence generation strategy

Evidence gap analysis
Data source landscaping
Assessment of payer acceptability
Payer rationalised clinical trial design
Development of cross-functional, real-world evidence strategy across the lifecycle

Our global market access strategy team work closely with our US access solutions team who cover US focused pricing and reimbursement, patient services and trade and channel services.